By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A US federal court has dismissed Illumina lawsuits alleging Affymetrix infringes on patents covering array technologies.

In a decision handed down on Tuesday, Judge Barbara Crabb of the US District Court for the Western District of Wisconsin granted summary judgment for Santa Clara, Calif.-based Affymetrix, saying the company does not infringe on US Patent numbers 7,510,841 and 7,612,020 and dismissed the cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.